heart-failure

Documents about heart-failure

• Coronary Artery Disease in Hearts Donated for Transplantation#837597ClinicalTrials.gov
• Exploring the Role of Nesprin1 in isoproterenol-induced heart failure: Insights into pathogenesis and therapeutic implications#446585PLOS
• Cardiac FDG PET Viability Registry#802028ClinicalTrials.gov
• Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure#129466HAL (France)
• HBP Device EGM Data Collection#136194ClinicalTrials.gov
• Empagliflozin and Atrial Fibrillation Treatment#181684ClinicalTrials.gov
• Bioavailability Study of BIA 5-453#184736ClinicalTrials.gov
• Heart Failure Trajectories After Guideline-Directed Medical Therapy.#221243NCBI PubMed Central
• Inhaled Nitrite in Subjects With Pulmonary Hypertension#238224ClinicalTrials.gov
• Heart failure risk prediction based on machine learning and interpretability analysis.#258210NCBI PubMed Central
• Prevention of Cardiac Dysfunction During Breast Cancer Therapy#287550ClinicalTrials.gov
• The emerging role of artificial intelligence in heart failure#365160PubMed Central
• HF-OCAQ: Oral comfort assessment in heart failure patients.#395856NCBI PubMed Central
• Assay to Measure Beta Blocker Adherence#831754ClinicalTrials.gov
• Impact of MayoExpertAdvisor on Provider Adherence#837051ClinicalTrials.gov
• Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism#840975ClinicalTrials.gov
• VITROS Immunodiagnostic Products NT-proBNP II#844586ClinicalTrials.gov
• Interchangeability of the KCCQ-12 and KCCQ-23 Across >18,000 Participants Enrolled in 4 Large-Scale Trials of Heart Failure#126788HAL (France)
• Renal replacement therapy in type 2 severe cardiorenal syndrome: a randomized controlled trial#202630HAL (France)
• Hyponatraemia and Changes in Natraemia During Hospitalization for Acute Heart Failure and Associations with In-Hospital and Long-Term Outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry#361951HAL (France)
• Impact of systemic inflammation on exercise haemodynamics in unexplained dyspnoea and heart failure with preserved ejection fraction#677827IRIS
• Acute Hemodynamic Instability After Transcatheter Tricuspid Valve Replacement#68263HAL (France)
• Increased Serum S100A12 Levels are Associated with Higher Risk of Acute Heart Failure in Patients with Type 2 Diabetes#262138HAL (France)
• Protective Effects of a Discontinuous Treatment with Alpha-Lipoic Acid in Obesity-Related Heart Failure with Preserved Ejection Fraction, in Rats#330364HAL (France)
• The value of cardiopulmonary exercise testing in determining severity in patients with both systolic heart failure and COPD#462318RI UFSCar
• Artificial Neural Network Heart Failure Prediction Using JNN#17733PhilArchive
• Heart Failure Prediction & Risk Stratification using Machine Learning#152662bioRxiv / medRxiv
• Monitoring Subjects With Fluid-Management Issues In the Home Environment#172412ClinicalTrials.gov
• Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals#184724ClinicalTrials.gov
• The Diagnosis and Management of Heart Failure across Primary and Secondary Care#231032Durham e-Theses
• Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers#257011ClinicalTrials.gov
• CHRONIC HEART FAILURE (CHF) AND NEW DRUGS: ANALYTICAL REVIEW OF EFFICACY#264536Zenodo (CERN)
• Initial Care Pathway in Acute Heart Failure From Home to Hospital#304505HAL (France)
• The Effects of Neprilysin on Glucagon-like Peptide-1#391019ClinicalTrials.gov
• Saxagliptin and Cardiac Structure and Function#460023ClinicalTrials.gov
• Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules#628610ClinicalTrials.gov
• Impact of Angiotensin Receptor- Neprilysin inhibition combined with enteral nutritional therapy on cardiac performance and inflammatory burden in hemodialysis-Associated heart failure: Clinical and experimental evidence#404999African Journals Online
• Effectiveness of Music Intervention on Anxiety and Physiological Responses in Critical Ill Patient#842084ClinicalTrials.gov
• Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)#172444ClinicalTrials.gov
• Effects of heart rate on cardiac function in normal mice and rats and in animal models of heart failure.#330882NCBI PubMed Central
• A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease#623570ClinicalTrials.gov
• Offline supervisory fuzzy control for weekly set-point adjustment in home-based congestive heart failure therapy#185572IRIS
• Table 4_Platycodin D alleviates cardiac hypertrophy in the treatment of heart failure by inhibiting p53-dependent BCL-2/Bax/caspase-3 signaling pathway.xlsx#224168Figshare
• Table 2_Platycodin D alleviates cardiac hypertrophy in the treatment of heart failure by inhibiting p53-dependent BCL-2/Bax/caspase-3 signaling pathway.xlsx#224172Figshare
• Table 3_Platycodin D alleviates cardiac hypertrophy in the treatment of heart failure by inhibiting p53-dependent BCL-2/Bax/caspase-3 signaling pathway.xlsx#224173Figshare
• Levosimendan in Acute Decompensated Heart Failure#825209ClinicalTrials.gov
• Quality of Life in Patients With Chronic Ischemic Heart Disease#828556ClinicalTrials.gov
• Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction#336296ResearchOnline@ND
• Personalized Exercise Therapy and Self-management Support for Patients With Multimorbidity#343726ClinicalTrials.gov
• Validation of the Peripheral Arterial Tone to Detect Sleep-disordered Breathing in Patients With Chronic Heart Failure#349903ClinicalTrials.gov